Bad to the bone: The effects of liver diseases on bone;Osteoporosi e malattie epatiche croniche

Minerva Medica

Volumn 95, Issue 6, 2004, Pages 489-505

  Marignani, M ^a   Angeletti, S ^a   Capurso, G ^a   Cassetta, S ^a   Delle Fave, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone loss; Bone metabolism; Chronic liver disease; Osteopenia; Osteoporosis

Indexed keywords

ADULT; BONE DENSITY; CHOLESTASIS; CHRONIC DISEASE; FEMALE; FRACTURE; HUMAN; LIVER CIRRHOSIS; MALE; OSTEOMALACIA; OSTEOPOROSIS; REVIEW;

ADULT; BONE DENSITY; CHOLESTASIS; CHRONIC DISEASE; FEMALE; FRACTURES, BONE; HUMANS; LIVER CIRRHOSIS; MALE; OSTEOMALACIA; OSTEOPOROSIS;

EID: 18444365273     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Heaf JG. Hepatic osteodystrophy. Scand J Gastroenterol 1985;20:1035-40.
2. CollierJD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 20O2;50:i1-i9.
3. Leslie WD, Bernstein CN, LeBoff MN. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003;125:941-66.
4. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:795-841.
5. Report of a WHO study group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994;843:1-129.
6. Ormarsdóttir S, Ljunggren O, Mallmin H, Brahm H, Loof L. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 1999;31:84-90.
7. Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999; 84:1867-71.
8. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987;7:137-42.
9. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989;96:213-21.
10. Hogson SF, Dickson ER, Heinz WW, Johnson KA, Mann KG. Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855-60.
11. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatits. Gut 1988:29:378-84.
12. Pietschmann P, Resch H, Muller C, Woloszczuk W, Willvonseder R. Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone Miner 1990;8:103-8.
13. Monegal A, Navata M, Guanabens N, Peris P, Martinez de Osaba MJ, Rimola A et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997;60:148-54.
14. Crawford BAL, Kam C, Donaghy AJ, McCaughan GW. The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 2003;14:987-94. Epub 2003 Sep 19.
15. Hay JE. Osteoporosis in liver disease and after liver transplantation. J Hepatol 2003;38:856-65.
16. Masuda S, Okano T, Osawa K, Shinjo M, Suematsu T, Kobayashi T. Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol Tokio 1989;35:225-34.
17. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990;31:82-7.
18. Jorge-Hernandez J, Gonzalez-Reimers C, Torres-Ramirez A, Santolaria-Fernandez F, Gonzalez-Garcia C, Batista-Lopez J et al. Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases. Dig Dis Sci 1988;33:1089-95.
19. de Seze S, Solnica J, Mitrovic D, Miravet L, Dorfmann H. Joint and bone disorders and hypoparathyroidism in hemochromatosis. Semin Arthritis Rheum 1972;2:71-94.
20. Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors. Ann Intern Med 1989;110:430-6.
21. Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 1991;6:39-43.
22. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995;95:2581-6.
23. Carey EJ, Balan V, Kremers WK, Hay JE. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis c and alcoholic liver disease: not just a cholestatic problem. Liver Transpl 2003;9:1166-73.
24. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
25. De Vos M, De Keyser F, Mielants H, Cuvelier C, Veys E. Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther 1998;12:397-404.
26. Hebuterne X, Schneider SM. Nutritional management of patients with liver disease. Nutr Clin Care 1999;2:300-8.
27. Shiomi S, Nishiguchi S, Kubo S, Tamori A, Habu D, Takeda T et al. Vitamin K2 (menantrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol 2002;97:578-81.
28. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-9.
29. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991;14:257-61.
30. Solerio E, Isaia G, Innarella R, Di Stefano M, Farina M, Borghesio E et al. Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig Liver Sci 2003;35:339-46.
31. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 1997;25:328-9.
32. Floreani AR, Betterle C, Baragiotta A, Martini S, Venturi C, Basso D et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult celiac disease patients in Italy. Dig Liver Dis 2002;34:258-61.
33. Volta U, Rodrigo L, Granito A, Petrolini N, Muratori P, Muratori L et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002;97:2609-31.
34. Marignani M, Angeletti S, Mari T, D'Alessandro P, Palumbo P, Dato A et al. Coeliac disease and autoimmune cholangitis: A case report. Digest Liver Dis 2002;34:862-5.
35. Marignani M, Angeletti S, Morini S. Osteoporosis and liver disease: Additional reasons for coeliac disease screening. Gut 2003;52:452.
36. Olsson R, Mattsson LA, Obrant K, Mellstrom D. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999;12:188-92.
37. Martini N. Dear doctor letter: Comunicazione sulla sicurezza della terapia ormonale sostitutiva (TOS). Rapporto beneficio rischio non favorevole quale terapia di prima scelta nella prevenzione dell'osteoporosi. Bollettino d'informazione sui farmaci 2003;(5-6):209-11.
38. Behre HM, von Eckardstein S, Klietsch S, Nieschlag E. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol 1999;50:629-35.
39. Rhoden EL, Morgentaler A. Risk of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004;350:482-92.
40. Wolfhagen FH, van Buuren HR, den Ouden JW, Hop WC, van Leeuwen JP, Schalm SW et al. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. J Hepatol 1997;26:325-30.
41. Guanabens N, Pares A, Ros I, Alvarez L, Pons F, Caballeria L et al. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 2003;98:2268-74.
42. Carey E, Balan V. Metabolic bone disease in patients with liver disease. Curr Gastroenterol Rep 2003;5:71-7.
43. Lindor K, Janes C, Crippin J, Jorgensen R, Dikson E. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995;21:389-92.